Aug 2026
Stage-resolved cytokine profiling nominates IL-17 as a prognostic node in relapsed/refractory B-cell lymphoma.
Findings indicate that IL-17 may be a potential biomarker with stage-specific clinical associations in B-NHL and warrants further investigation for risk stratification and individualized treatment monitoring.
Xinlu Jiang, Xiao-Yu Wang, Li Yan et al.
· Cytokine · 0 citations